Literature DB >> 12829795

Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo.

Jennifer L Matsuda1, Laurent Gapin, Jody L Baron, Stéphane Sidobre, Daniel B Stetson, Markus Mohrs, Richard M Locksley, Mitchell Kronenberg.   

Abstract

Under different circumstances, natural killer T (NKT) cells can cause a T helper (Th) 1 or a Th2 polarization of immune responses. We show here, however, that mouse NKT cells with an invariant V alpha 14 rearrangement (V alpha 14i NKT cells) rapidly produce both IL-4 and IFN-gamma, and this pattern could not be altered by methods that polarize naive CD4+ T cells. Surprisingly, although cytokine protein was detected only after activation, resting V alpha 14i NKT cells contained IL-4 and IFN-gamma mRNAs. Despite this finding, in vivo priming of mice with the glycolipid antigen recognized by V alpha 14i NKT cells resulted in a more Th2-oriented response upon antigen re-exposure. The V alpha 14i NKT cells from primed mice retain the ability to produce IL-4 and IFN-gamma, but they are less effective at activating NK cells to produce IFN-gamma. Our data therefore indicate that V alpha 14i NKT cells have a relatively inflexible immediate cytokine response, but that changes in their ability to induce IFN-gamma secretion by NK cells may determine the extent to which they promote Th1 responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829795      PMCID: PMC166240          DOI: 10.1073/pnas.1332805100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  58 in total

1.  Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.

Authors:  G Eberl; H R MacDonald
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

2.  Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; H Sato; E Kondo; M Harada; H Koseki; T Nakayama; Y Tanaka; M Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells.

Authors:  S O'Gorman; N A Dagenais; M Qian; Y Marchuk
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.

Authors:  K Kawakami; Y Kinjo; S Yara; Y Koguchi; K Uezu; T Nakayama; M Taniguchi; A Saito
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

Authors:  S Hong; M T Wilson; I Serizawa; L Wu; N Singh; O V Naidenko; T Miura; T Haba; D C Scherer; J Wei; M Kronenberg; Y Koezuka; L Van Kaer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

6.  CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.

Authors:  Edward E S Nieuwenhuis; Tetsuya Matsumoto; Mark Exley; Robbert A Schleipman; Jonathan Glickman; Dan T Bailey; Nadia Corazza; Sean P Colgan; Andrew B Onderdonk; Richard S Blumberg
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

7.  Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.

Authors:  Z Illés; T Kondo; J Newcombe; N Oka; T Tabira; T Yamamura
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

8.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.

Authors:  T Kawabe; T Naka; K Yoshida; T Tanaka; H Fujiwara; S Suematsu; N Yoshida; T Kishimoto; H Kikutani
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

9.  A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.

Authors:  M Falcone; B Yeung; L Tucker; E Rodriguez; N Sarvetnick
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Authors:  H Kitamura; K Iwakabe; T Yahata; S Nishimura; A Ohta; Y Ohmi; M Sato; K Takeda; K Okumura; L Van Kaer; T Kawano; M Taniguchi; T Nishimura
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

View more
  92 in total

Review 1.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 2.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

3.  Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.

Authors:  Jerome Kerzerho; Esther D Yu; Carolina M Barra; Elisenda Alari-Pahissa; Elisenda Alari-Pahisa; Enrico Girardi; Youssef Harrak; Pilar Lauzurica; Amadeu Llebaria; Dirk M Zajonc; Omid Akbari; A Raúl Castaño
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

4.  Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses.

Authors:  Lisa A Mannik; Ian Chin-Yee; Shayan Sharif; Luc Van Kaer; Terry L Delovitch; S M Mansour Haeryfar
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

5.  NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.

Authors:  Adam P Uldrich; Nadine Y Crowe; Konstantinos Kyparissoudis; Daniel G Pellicci; Yifan Zhan; Andrew M Lew; Philippe Bouillet; Andreas Strasser; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

Review 6.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

7.  Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.

Authors:  Yoshinori Ikarashi; Akira Iizuka; Yumie Koshidaka; Yuji Heike; Yoichi Takaue; Mitsuzi Yoshida; Mitchell Kronenberg; Hiro Wakasugi
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

8.  Induction and maintenance of IL-4 expression are regulated differently by the 3' enhancer in CD4 T cells.

Authors:  M Hanief Sofi; Yu Qiao; K Mark Ansel; Masato Kubo; Cheong-Hee Chang
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

Review 9.  The role of invariant natural killer T cells in lupus and atherogenesis.

Authors:  Amy S Major; Ram R Singh; Sebastian Joyce; Luc Van Kaer
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

10.  An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.

Authors:  D Ly; R Tohn; B Rubin; H Blumenfeld; G S Besra; N Veerapen; S A Porcelli; T L Delovitch
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.